49281-575 : Beyfortus 50 mg/.5ml Intramuscular Injection
NDC: | 49281-575 |
Labeler: | Sanofi Pasteur Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Beyfortus |
Dosage Form: | Intramuscular Injection |
Application #: | BLA761328 |
Rev. Date: |
NDC Package Codes:
- 49281-575-00: 1 SYRINGE IN 1 CARTON (49281‑575‑00) / .5 ML IN 1 SYRINGE
- 49281-575-15: 5 SYRINGE IN 1 CARTON (49281‑575‑15) / .5 ML IN 1 SYRINGE
Active Ingredients:
- Nirsevimab
Dosage Strength:
- 50 mg/.5mL
Pharmaceutical Classes:
- Fusion Protein Inhibitors [MoA]
- Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]
Related Products:
Based on records with the same trade name.- 49281-574 Beyfortus 100 mg/ml Intramuscular Injection by Sanofi Pasteur Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 49281-574Next: 49281-589 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.